A decrease of about -30.58% in the sales to Rs. 688.92 millions was observed for the quarter ended March 2019. The sales stood at Rs. 992.43 millions during the similar quarter previous year.Profit after Tax for the quarter ended March 2019 saw a decline of -53.45% from Rs. 373.06 millions to Rs. 173.67  millions.Operating Profit reported a sharp decline to 292.00 millions from 609.49 millions in the corresponding previous quarter. (Rs. in Million) Quarter ended Year to Date Year ended 201903 201803 % Var 201903 201803 % Var 201803 201703 % Var Sales 688.92 992.43 -30.58 4015.02 3122.86 28.57 3104.30 2615.75 18.68 Other Income 59.94 31.57 89.86 191.09 102.44 86.54 101.36 61.87 63.83 PBIDT 292.00 609.49 -52.09 2452.31 1549.73 58.24 1548.66 758.71 104.12 Interest 7.14 4.18 70.81 7.32 6.14 19.22 5.06 22.10 -77.10 PBDT 284.86 605.31 -52.94 2444.99 1554.18 57.32 1554.19 659.72 135.58 Depreciation 22.92 22.78 0.61 92.31 91.91 0.44 91.92 89.27 2.97 PBT 261.94 582.53 -55.03 2352.68 1462.27 60.89 1462.27 570.45 156.34 TAX 88.27 209.47 -57.86 822.35 511.10 60.90 511.10 191.63 166.71 Deferred Tax -1.11 82.69 -101.34 0.87 89.82 -99.03 89.82 44.78 100.58 PAT 173.67 373.06 -53.45 1530.33 951.17 60.89 951.17 378.83 151.08 Equity 57.47 57.47 0.00 57.47 57.47 0.00 57.47 57.47 0.00 PBIDTM(%) 42.39 61.41 -30.98 61.08 49.63 23.08 49.89 29.01 71.99

National Peroxide is currently trading at Rs. 1483.90, up by 28.75 points or 1.98% from its previous closing of Rs. 1455.15 on the BSE.The scrip opened at Rs. 1461.00 and has touched a high and low of Rs. 1499.00 and Rs. 1425.00 respectively. So far 5188 shares were traded on the counter.The BSE group `XC` stock of face value Rs. 10 has touched a 52 week high of Rs. 1545.00 on 10-Aug-2017 and a 52 week low of Rs. 645.00 on 11-Aug-2016.Last one week high and low of the scrip stood at Rs. 1545.00 and Rs. 1386.00 respectively. The current market cap of the company is Rs. 851.13 crore.The promoters holding in the company stood at 70.68%, while Institutions and Non-Institutions held 0.01% and 29.30% respectively.National Peroxide has received its board’s approval for capacity expansion of its Hydrogen Peroxide Plant at Kalyan (on 50% w/w basis) from 95,000 tonnes per annum to 1,50,000 tonnes per annum. The company’s board gave approval for the same at the meeting held on August 9, 2017.National Peroxide is engaged in the manufacturers of chemicals hydrogen peroxide and sodium perborate.

National Peroxide is currently trading at Rs. 1500.00, up by 103.60 points or 7.42% from its previous closing of Rs. 1396.40 on the BSE.The scrip opened at Rs. 1425.00 and has touched a high and low of Rs. 1545.00 and Rs. 1425.00 respectively. So far 15,000 shares were traded on the counter.The BSE group `XC` stock of face value Rs. 10 has touched a 52 week high of Rs. 1545.00 on 10-Aug-2017 and a 52 week low of Rs. 645.00 on 11-Aug-2016.Last one week high and low of the scrip stood at Rs. 1545.00 and Rs. 1386.00 respectively. The current market cap of the company is Rs. 862.00 crore.The promoters holding in the company stood at 70.68%, while Institutions and Non-Institutions held 0.01% and 29.30% respectively.National Peroxide has received its board’s approval for capacity expansion of its Hydrogen Peroxide Plant at Kalyan (on 50% w/w basis) from 95,000 tonnes per annum to 1,50,000 tonnes per annum. The company’s board gave approval for the same at the meeting held on August 9, 2017.National Peroxide is engaged in the manufacturers of chemicals hydrogen peroxide and sodium perborate.

The June 2017 quarter revenue stood at Rs. 768.54 millions, up 17.99% as compared to Rs. 651.34 millions during the corresponding quarter last year.The company has announced a 47.24% increase in its profits to Rs . 179.49  millions for the  quarter ended June 2017 compared to Rs. 121.90 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 294.81 millions from 226.14 millions in the quarter ended June 2017. (Rs. in Million) Quarter ended Year to Date Year ended 201706 201606 % Var 201706 201606 % Var 201703 201603 % Var Sales 768.54 651.34 17.99 768.54 651.34 17.99 2554.56 2335.35 9.39 Other Income 19.15 14.89 28.61 19.15 14.89 28.61 60.34 80.77 -25.29 PBIDT 294.81 226.14 30.37 294.81 226.14 30.37 726.73 439.57 65.33 Interest 1.62 7.80 -79.23 1.62 7.80 -79.23 21.35 53.85 -60.35 PBDT 293.19 218.34 34.28 293.19 218.34 34.28 744.71 376.57 97.76 Depreciation 22.86 22.05 3.67 22.86 22.05 3.67 89.27 89.56 -0.32 PBT 270.33 196.29 37.72 270.33 196.29 37.72 655.44 287.01 128.37 TAX 90.84 74.39 22.11 90.84 74.39 22.11 176.96 107.30 64.92 Deferred Tax 5.30 10.64 -50.19 5.30 10.64 -50.19 15.60 19.60 -20.41 PAT 179.49 121.90 47.24 179.49 121.90 47.24 478.48 179.71 166.25 Equity 57.47 57.47 0.00 57.47 57.47 0.00 57.47 57.47 0.00 PBIDTM(%) 38.36 34.72 10.49 38.36 34.72 10.49 28.45 18.82 51.14

A fair growth of 13.32% in the revenue at Rs. 675.45 millions was reported in the March 2017 quarter as compared to Rs. 596.04 millions during year-ago period.Net Profit witnessed a 122.86% growth almost the double from Rs. 70.43 millions to Rs. 156.96  millions  of same quarter last year.The Operating Profit of the company witnessed a decrease to 158.32 millions from 158.62 millions. (Rs. in Million) Quarter ended Year to Date Year ended 201703 201603 % Var 201703 201603 % Var 201603 201503 % Var Sales 675.45 596.04 13.32 2554.57 2335.36 9.39 2335.35 1962.96 18.97 Other Income 13.55 17.95 -24.51 60.35 80.77 -25.28 80.77 63.66 26.88 PBIDT 158.32 158.62 -0.19 726.73 439.58 65.32 439.59 283.04 55.31 Interest 5.35 10.15 -47.29 21.36 53.86 -60.34 53.86 46.84 14.99 PBDT 192.30 139.32 38.03 744.70 376.57 97.76 376.58 236.20 59.43 Depreciation 22.48 22.40 0.36 89.27 89.57 -0.33 89.57 72.13 24.18 PBT 169.82 116.92 45.24 655.44 287.00 128.38 287.01 164.07 74.93 TAX 12.86 46.49 -72.34 176.96 107.29 64.94 107.30 101.72 5.49 Deferred Tax 4.90 3.90 25.64 4.90 3.90 25.64 0.00 0.00 0.00 PAT 156.96 70.43 122.86 478.48 179.71 166.25 179.71 62.35 188.23 Equity 0.00 57.47 0.00 57.47 57.47 0.00 57.47 57.47 0.00 PBIDTM(%) 23.44 26.61 -11.92 28.45 18.82 51.14 18.82 14.42 30.55

National Peroxide has informed that a meeting of the Board of Directors of the Company will be held on February 14, 2017, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2016. Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window in respect of the Company’s securities shall remain closed from January 23 2017 till 48 hours after the Unaudited Financial Results of the Company are made public.The above information is a part of company’s filings submitted to BSE.

National Peroxide has informed about authorised Key Managerial Personnel to determine materiality of events/information.The above information is a part of company’s filings submitted to BSE.

National Peroxide has informed that the Board of Directors of the Company at its meeting held on May 26, 2016, has recommended a Dividend of Rs 10 per equity share of Rs 10 each (100%), to the Equity Shareholders of the Company for declaration at the ensuing Annual General Meeting.The above information is a part of company’s filings submitted to BSE.

National Peroxide has informed about authorised Key Managerial Personnel to determine materiality of events/information.The above information is a part of company’s filings submitted to BSE.

National Peroxide has submitted a copy of proceedings of the 61st Annual General Meeting of the Company held on August 11, 2015.The above information is a part of company’s filings submitted to BSE.

National Peroxide has informed that the Register of Members & Share Transfer Books of the Company will remain closed from July 29, 2015 to August 11, 2015 for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on August 11, 2015.The above information is a part of company’s filings submitted to BSE.

National Peroxide has informed that Hema Hattangady, Non - Executive Independent Director, has resigned from the Board of Directors of the Company with effect from July 2, 2015.The above information is a part of company’s filings submitted to BSE.